https://pharminent.com/rare-disease-gene-therapy/rare-disease-gene-therapy-digest-may-28-2026/ 2026-05-29T02:44:03Z Pharminent en Rare Disease & Gene Therapy Digest • May 28, 2026 2026-05-29T02:43:59Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-may-28-2026/ 2026-05-28T18:43:55Z Pharminent en Strategic News Watch • May 28, 2026 2026-05-28T18:43:50Z Blog https://pharminent.com/cvs-obesity-drug-deal-puts-lilly-on-equal-footing-with-novo/ 2026-05-28T15:34:46Z Pharminent en CVS obesity drug deal puts Lilly on equal footing with Novo 2026-05-28T15:09:00Z Blog https://pharminent.com/gsk-hails-unprecedented-cure-rates-with-hep-b-drug/ 2026-05-28T15:34:52Z Pharminent en GSK hails 'unprecedented' cure rates with hep B drug 2026-05-28T12:05:56Z Blog https://pharminent.com/abbvie-snags-fdas-first-adc-approval-for-ultra-rare-blood-cancer/ 2026-05-28T15:34:56Z Pharminent en AbbVie snags FDA's first ADC approval for ultra-rare blood cancer 2026-05-28T11:27:47Z Blog https://pharminent.com/neuromarket-pulse/neuromarket-pulse-weekly-neuroscience-competitive-intelligence-may-27-2026/ 2026-05-27T22:27:25Z Pharminent en NeuroMarket Pulse • Weekly Neuroscience Competitive Intelligence • May 27, 2026 2026-05-27T22:27:21Z Blog https://pharminent.com/manufacturing-intelligence/manufacturing-intelligence-weekly-digest-may-27-2026/ 2026-05-27T21:49:02Z Pharminent en Manufacturing Intelligence • Weekly Digest • May 27, 2026 2026-05-27T21:48:59Z Blog https://pharminent.com/81130-2/ 2026-05-27T21:43:03Z Pharminent en 2026-05-27T21:42:57Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-may-27-2026/ 2026-05-27T17:31:58Z Pharminent en Strategic News Watch • May 27, 2026 2026-05-27T17:31:53Z Blog https://pharminent.com/apogee-investors-riled-by-1-3b-royalty-deal-as-eczema-drug-matches-lillys-ebglyss/ 2026-05-27T16:09:42Z Pharminent en Apogee investors riled by $1.3B royalty deal, as eczema drug matches Lilly's Ebglyss 2026-05-27T15:15:18Z Blog https://pharminent.com/kardigan-targets-ipo-to-support-cardiology-pipeline-progression/ 2026-05-27T16:09:48Z Pharminent en Kardigan targets IPO to support cardiology pipeline progression 2026-05-27T14:06:51Z Blog https://pharminent.com/fda-delays-verdict-on-az-breast-cancer-drug/ 2026-05-27T16:09:52Z Pharminent en FDA delays verdict on AZ breast cancer drug 2026-05-27T12:47:03Z Blog https://pharminent.com/oncology/oncology-intelligence-digest-may-26-2026/ 2026-05-27T01:14:59Z Pharminent en Oncology Intelligence Digest • May 26, 2026 2026-05-27T01:14:56Z Blog